Dasatinib

Dasatinib
Avin India has been supplying Dasatinib 302962-49-8 in the International and Domestic market.
We take care of timely deliveries and provide necessary sales and after sales support to the customers.
Manufacturers associated with Avin India are quality driven and have GMP or WHO-GMP facility which can meet our customer’s requirement regarding their regulatory compliance and specification needs.
Dasatinib 302962-49-8 with documents EUGMP, cGMP, USFDA, GMP, Halal-Kosher, Korea FDA USDMF, EDMF, DMF (OPEN PART), DMF (CLOSED PART) CEP / COS, PMDA – JAPAN, DMF – CANADA, TGA – AUSTRALIA, , MHRA – UK, DMF – KOREA, AIFA – ITALY, TDP, HEALTH CANADA, MEDSAFE – NEW ZEALAND , JDMF, JAPAN – AFM, DMF – CTD, DCGI, ICH, COPP, TDMF will be provided as per customer requirement.
We can also offer the Intermediates of Dasatinib 302962-49-8.
Synonyms – N-(2-chloro-6-Methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-Methyl-4-pyriMidinyl]aMino]-1,3-thiazole-5-carboxaMide;sprycel Dasatinib;BMS-354825; SPRYCEL;25MG/100MG/1G;NCGC00181129;Dasatinib (Dasatinib Monohydrate) Tablet;Dasatinib (anhydrous);Dasatinib, 95+%
CAS Number – 302962-49-8
Molecular Formula – C22H26ClN7O2S
Molecular Weight – 488.01
Packing – All Types Of Packing Available
Packing – All Types Of Packing Available
Specification – IP/BP/EP/USP
Share this product
Application
Oncology
Oncology